Yi Zhang

Yi Zhang

Auto-generated profile, based on publicly available information

Yi Zhang

Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2016 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
MLMengting Liu
Mengting Liu
XLXin Liu
Xin Liu
HWHongping Wang
Hongping Wang
HXHongbin Xiao
Hongbin Xiao
FJFang Jing
Fang Jing
HYHongjun Yang
Hongjun Yang

29 May 2015 in Molecules
Verified
Journal Article
Open access
PDF file
WHWu Hongwei
Wu Hongwei
PWPeng Wang
Peng Wang
MLMengting Liu
Mengting Liu
LTLiying Tang
Liying Tang
JFJing Fang
Jing Fang
HYHongjun Yang
Hongjun Yang
Corydalis Rhizoma, named YuanHu in China, is the dried tuber of Corydalis yanhusuo W.T. Wang which is used in Traditional Chinese Medicine for pain relief and blood activation. Previous pharmacological studies showed that apart from analgesics, the alkaloids from YuanHu may be useful in the therapy of depression by acting on the GABA, dopamine and benzodiazepine receptors. In this study, the antidepressive effect of the total alkaloid of YuanHu (YHTA) was investigated in a chronic unpredictable mild stress (CUMS) rat model using 1H-NMR-based metabonomics. Plasma metabolic profiles were analyzed and multivariate data analysis was applied to discover the metabolic biomarkers in CUMS rats. Thirteen biomarkers of CUMS-introduced depression were identified, which are myo-inositol, glycerol, glycine, creatine, glutamine, glutamate, β-glucose, α-glucose, acetoacetate, 3-hydroxybutyrate, leucine and unsaturated lipids (L7, L9). Moreover, a metabolic network of the potential biomarkers in plasma perturbed by CUMS was detected. After YHTA treatment, clear separation between the model group and YHTA-treated group was achieved. The levels of all the abnormal metabolites mentioned above showed a tendency of restoration to normal levels. The results demonstrated the therapeutic efficacy of YHTA against depression and suggested that NMR-based metabolomics can provide a simple and easy tool for the evaluation of herbal therapeutics.

31 March 2023 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
GCGuangzhao Cao
Guangzhao Cao
JHJingyi Hou
Jingyi Hou
RZRui Zhou
Rui Zhou
LTLiang-Liang Tian
Liang-Liang Tian
MWMao-Lin Wang
Mao-Lin Wang
JZJingjing Zhang
Jingjing Zhang

20 March 2019 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
JXJing Xu
Jing Xu
XLXin Liu
Xin Liu
LLLiyu Luo
Liyu Luo
LTLiying Tang
Liying Tang
NGNa Guo
Na Guo
HYHongjun Yang
Hongjun Yang
Background. Amino acids (AAs) in cerebrospinal fluid (CSF) play a pivotal role in cerebral ischemia (CI). BuChang NaoXinTong Capsules (BNC) are widely prescribed in Chinese medicine for the treatment of cerebrovascular and cardiovascular diseases. Methods. In order to investigate the therapeutic effects and pharmacological mechanisms of BNC on reversing CI from a system level, an amino acid-protein interaction imbalanced network of CI containing metabolites of AAs, key regulatory enzymes, and proteins was constructed for the first time. Furthermore, a novel method for detecting the ten AAs in CSF was developed by UPLC-QQQ-MS in an effort to validate the imbalanced networks and the therapeutic effects of BNC via analysis of metabolites. Results. Based on a middle cerebral artery occlusion (MCAO) rat model, the dynamic levels of amino acids in CSF 3, 6, 12, and 24 h after MCAO were analyzed. Up to 24 h, the accumulated nine AA biomarkers were found to significantly change in the MCAO group compared to the sham group and exhibited an obvious tendency for returning to baseline values after BNC treatment. In addition, based on the imbalanced network of CI, four key enzymes that regulate the generation of BNC-mediated AA biomarkers were selected and validated using an enzyme-linked immunosorbent assay and western blotting. Finally, aromatic-L-amino-acid decarboxylase (AADC) was found to be one of the putative targets for BNC-mediated protection against CI. Conclusion. This study provides new strategies to explore the mechanism of cerebral ischemia and help discover the potential mechanism of BNC.

13 January 2022 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
GCGuangzhao Cao
Guangzhao Cao
CXChangpei Xiang
Changpei Xiang
RZRui Zhou
Rui Zhou
YZYi Zhang
Yi Zhang
HXHe Xu
He Xu
JZJingjing Zhang
Jingjing Zhang
Diabetic ulcers bring about high morbidity and mortality in patients and cause a great economic burden to society as a whole. Since existing treatments cannot fulfil patient requirements, it is urgent to find effective therapies. In this study, the wound healing effect of topical notoginsenoside R1 (NR1) treatment on diabetic full‐thickness wounds in type II diabetes mellitus (T2DM) was induced by the combination of a high‐fat diet and streptozotocin (STZ) injection. NR1 significantly increased the wound closure rate, enhanced extracellular matrix (ECM) secretion, promoted collagen growth, increased platelet endothelial cell adhesion molecule‐1 (CD31) expression, and decreased cleaved caspase‐3 expression. RNA‐Seq analysis identified ECM remodeling and inflammation as critical biological processes and Timp1 and Mmp3 as important targets in NR1‐mediated wound healing. Further experiments showed that NR1‐treated wounds demonstrated higher expression of tissue inhibitor of metalloproteinase 1 (TIMP1) and transforming growth factor‐β1 (TGFβ1) and lower expression of matrix metallopeptidase 9 (MMP9), matrix metallopeptidase 3 (MMP3), interleukin‐1β (IL‐1β), and interleukin‐6 (IL‐6) than diabetic wounds. These investigations promote the understanding of the mechanism of NR1‐mediated diabetic wound healing and provide a promising therapeutic drug to enhance diabetic wound healing.

1 December 2019 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
JEji enhui
ji enhui
TWTingting Wang
Tingting Wang
FGFeifei Guo
Feifei Guo
YZYi Zhang
Yi Zhang
CTChunyu Tang
Chunyu Tang
MXMinghua Xian
Minghua Xian
To evaluate whether Xiaoerfupi (XEFP), a traditional Chinese medicine formula, can ameliorate functional dyspepsia (FD) through regulation of the HTR3A and c-FOS. The FD rat model was established through administration of iodoacetamide (IA) and interval fasting. XEFP group rats received XEFP for 3 weeks. Detection of gastric emptying and gastrin were performed to assess the interventional effect of XEFP. The constituents of XEFP were submitted to BATMAN-TCM, an online bioinformatics analysis tool, to predict the targets related to dyspepsia. Furthermore, the prediction was validated via Western blot assay. XEFP enhanced gastric emptying of rats (XEFP middle dose vs. FD model: 71.87 ± 15.21% vs. 30.07 ± 12.76%, P < 0.01) and simultaneously increased gastrin in FD rats (XEFP middle dose vs. FD model: 63.61 ± 17.90 vs. 26.14 ± 7.78 pg/ml, P < 0.01). KEGG enrichment analysis revealed that the neuroactive ligand-receptor interaction was successfully enriched (P-value = 2.2E-13, Benjamini = 2.0E-11). Combining different Bioinformatics analysis implied that XEFP regulates HTR3A and c-FOS. Subsequently molecular biological studies confirmed that the expression of HTR3A and c-FOS in the model group was upregulated in rats in comparison with the control group. Furthermore, the expression of HTR3A and c-FOS in the XEFP group (middle dose) compared with the model group was significantly reduced (P < 0.01). XEFP may ameliorate FD through regulation of the HTR3A and c-FOS.